You are here:Home-Chemical Inhibitors & Agonists-Others-Other Targets-GSK-2256294A
GSK-2256294A

Chemical Structure : GSK-2256294A

CAS No.: 1142090-23-0

GSK-2256294A (GSK-2256294)

Catalog No.: PC-45669Not For Human Use, Lab Use Only.

A potent, selective soluble epoxide hydrolase (sEH, EPHX2) inhibitor with IC50 of 27/61/189 pM for recombinant human/rat/mouse sEH, respectively.

Packing Price Stock Quantity
10 mg $280 In stock
50 mg $680 In stock
100 mg $960 In stock

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

A potent, selective soluble epoxide hydrolase (sEH, EPHX2) inhibitor with IC50 of 27/61/189 pM for recombinant human/rat/mouse sEH, respectively; exhibites potent cell-based activity, a concentration-dependent inhibition of the conversion of 14,15-EET to 14,15-DHET in human (IC50=6.83 nM), rat and mouse whole blood in vitro, and a dose-dependent increase in the LTX/LTX diol ratio in rats; orally active.

Physicochemical Properties

M.Wt 447.4568
Formula C21H24F3N7O
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

DMSO: ≥ 47 mg/mL

Chemical Name/SMILES

Cyclohexanecarboxamide, N-[[4-cyano-2-(trifluoromethyl)phenyl]methyl]-3-[[4-methyl-6-(methylamino)-1,3,5-triazin-2-yl]amino]-, (1R,3S)-

References

1. Podolin PL, et al. Prostaglandins Other Lipid Mediat. 2013 Jul-Aug;104-105:25-31.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: